Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes -: Early Treatment Diabetic Retinopathy Study Report no. 27

被引:136
|
作者
Cusick, M
Meleth, AD
Agrón, E
Fisher, MR
Reed, GF
Knatterud, GL
Barton, FB
Davis, MD
Ferris, FL
Chew, EY
机构
[1] NEI, NIH, Bethesda, MD 20892 USA
[2] NIH, Howard Hughes Med Inst, Bethesda, MD 20892 USA
[3] Univ Wisconsin, Dept Ophthalmol, Madison, WI USA
[4] Maryland Med Res Inst, Baltimore, MD USA
[5] EMMES, Rockville, MD USA
关键词
D O I
10.2337/diacare.28.3.617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Diabetes is a leading cause of morbidity and mortality. The purpose of this study is to assess the associations between diabetes complications and mortality in the Early Treatment Diabetic Retinopathy Study (ETDRS). RESEARCH DESIGN AND METHODS - We examined demographic, clinical, and laboratory characteristics of the 3,711 subjects enrolled in the ETDRS, a randomized controlled clinical trial designed to evaluate the role of laser photocoagulation and aspirin therapy for diabetic retinopathy. The outcome assessed was all-cause mortality. Multivariable Cox proportional hazards regression was used to assess associations between diabetes complications and mortality for type 1 and type 2 diabetes separately. RESULTS - The 5-year estimates of all-cause mortality were 5.5 and 18.9% for patients with type 1 and type 2 diabetes, respectively. In patients with type 1 diabetes, amputation (hazard ratio [HR] 5.08 [95% CI 2.06-12.54]) and poor visual acuity (1.74 [1.10-2.75]) remained significantly associated with mortality, after adjusting for other diabetes complication's and baseline characteristics. In patients with type 2 diabetes, macrovascular disease and worsening levels of nephropathy, neuropathy, retinopathy, and visual acuity are associated with progressively increasing risks of mortality, after controlling for other baseline risk factors. CONCLUSIONS - Amputation is the strongest predictor for mortality in. patients. with type 1 diabetes. All complications independently predict mortality in patients with type 2 diabetes. There is an increased risk for mortality as the degree of each complication worsens. Additional studies are needed to investigate the effectiveness of tertiary prevention to decrease mortality in these patients.
引用
收藏
页码:617 / 625
页数:9
相关论文
共 50 条
  • [1] Vitamin D Is Not Associated With Diabetic Retinopathy in Patients With Type 1 Diabetes and Type 2 Diabetes
    Brix, Johanna M.
    Dossenbach-Glaninger, Astrid
    Brunner, Simon
    Krzizek, Eva
    Schernthaner, Gerit H.
    Schernthaner, Guntram
    DIABETES, 2012, 61 : A156 - A156
  • [2] Vitamin D is not associated with diabetic Retinopathy in Patients with Type 1 and Type 2 Diabetes
    Krzizek, Eva
    Dossenbach-Glaninger, Astrid
    Brunner, Simon
    Brix, Johanna-Maria
    Schernthaner, Gerit-Holger
    Schernthaner, Guntram
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 : 14 - 14
  • [3] Progression of diabetic complications in patients with type 1 diabetes
    Glazunova, A.
    Arutyunova, M.
    Shamkhalova, M.
    Shestakova, M.
    Moysyuk, Y.
    Pinchuk, A.
    Dmitriev, I.
    Arzumanov, S.
    Dedov, I.
    DIABETOLOGIA, 2017, 60 : S207 - S207
  • [4] The annual incidence of diabetic complications in a population of patients with Type 1 and Type 2 diabetes
    McAlpine, RR
    Morris, AD
    Emslie-Smith, A
    James, P
    Evans, JMM
    DIABETIC MEDICINE, 2005, 22 (03) : 348 - 352
  • [5] PREVALENCE OF DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
    Esteves, Jorge F.
    Kramer, Caroline K.
    de Azevedo, Mirela Jobim
    Stolz, Andressa P.
    Roggia, Murilo F.
    Larangeira, Andreia
    Miozzo, Suellen A.
    Rosa, Carolina
    Lambert, Jose Humberto
    Pecis, Miriam
    Rodrigues, Ticiana C.
    Santos Canani, Luis Henrique
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2009, 55 (03): : 268 - 273
  • [6] IMAGING BIOMARKERS IN DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 1 DIABETES
    Poluboyarinova, I.
    Fadeyev, V.
    Karamullina, R.
    Pavlov, V.
    Budzinskaya, M.
    Petrachkov, D.
    Durzhinskaya, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A242 - A243
  • [7] Diabetic retinopathy in type 1 diabetes patients in Western Norway
    Jansson, Ragnhild W.
    Hufthammer, Karl Ove
    Krohn, Jorgen
    ACTA OPHTHALMOLOGICA, 2018, 96 (05) : 465 - 474
  • [8] Diabetic Retinopathy and Dementia in Type 1 Diabetes
    Rodill, Liora G.
    Exalto, Lieza G.
    Gilsanz, Paola
    Biessels, Geert Jan
    Quesenberry, Charles P., Jr.
    Whitmer, Rachel A.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2018, 32 (02): : 125 - 130
  • [9] DIABETIC RETINOPATHY IN CHILDREN WITH TYPE 1 DIABETES
    Samalia, Priya
    Jefferies, Craig
    Dai, Shuan
    Squirrell, David
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 112 - 112
  • [10] Metabolic control and diabetic retinopathy in patients with diabetes type 2
    Kosanovic-Jakovic, N.
    Resan, M.
    Dimitrijevic-Sreckovic, V.
    Vukosavljevic, M.
    Milenkovic, S.
    Colak, E.
    Risovic, D.
    Avramovic, S.
    Canovic, F.
    SPEKTRUM DER AUGENHEILKUNDE, 2010, 24 (03) : 157 - 161